journal article·2007-05

In vivo performance of antibiotic embedded electrospun PCL membranes for prevention of abdominal adhesions

N. Bölgen, İ. Vargel, P. Korkusuz, Y. Z. Menceloğlu, E. Pişkin

Publisher page

Abstract

Abstract The aim of this study was to prepare nonwoven materials from poly(ε‐caprolactone) (PCL) and their antibiotic containing forms by electrospinning, so as to prevent postsurgery induced abdominal adhesions in rats. ε‐Caprolactone was first polymerized by ring‐opening polymerization, and then it was processed into matrices composed of nanofibers by electrospinning. A model antibiotic (Biteral®) was embedded within a group of PCL membranes. In the rat model, defects on the abdominal walls in the peritoneum were made to induce adhesion. The plain or antibiotic embedded PCL membranes were implanted on the right side of the abdominal wall. No membrane implantation was made on the left side of the abdominal wall that served as control. Macroscopical and histological evaluations showed that using these barriers reduces the extent, type, and tenacity of adhesion. The antibiotic embedded membranes significantly eliminated postsurgery abdominal adhesions, and also improved healing. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Intestinal and Peritoneal Adhesions · Electrospun Nanofibers in Biomedical Applications · Hernia repair and management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. 10.1016/S0015-0282(00)00656-710.1016/S0015-0282(00)00656-7 ↗
2. 10.1016/S0039-6109(05)70574-010.1016/S0039-6109(05)70574-0 ↗
3. Peritoneal adhesions: Incidence, cause and prevention
4. Postoperative adhesions: Their treatment and relevance in clinical practise
5. 10.1002/bjs.180061040610.1002/bjs.1800610406 ↗
6. Wiseman D · 1994 · 370
7. 10.1016/S0015-0282(97)00574-810.1016/S0015-0282(97)00574-8 ↗
8. Prevention of postoperative abdominal adhesions by a sodium hylarunate‐based bioresorbable membrane: A prospective, randomized, double‐blind multicenter study
9. 10.1016/S0015-0282(16)56507-810.1016/S0015-0282(16)56507-8 ↗
10. 10.1016/0028-2243(94)90114-710.1016/0028-2243(94)90114-7 ↗
11. 10.1017/S096227990000122810.1017/S0962279900001228 ↗
12. 10.1093/humrep/15.6.135810.1093/humrep/15.6.1358 ↗
13. 10.1016/S0015-0282(16)57541-410.1016/S0015-0282(16)57541-4 ↗
14. 10.1016/S0015-0282(16)54559-210.1016/S0015-0282(16)54559-2 ↗
15. Assesment of carboxymethylcellulose and %32 Dextran 70 for prevention of adhesions in a rabbit uterine horn model
16. 10.1006/jsre.1993.116310.1006/jsre.1993.1163 ↗
17. 10.1002/bjs.180078041410.1002/bjs.1800780414 ↗
18. 10.1016/S0015-0282(97)81472-010.1016/S0015-0282(97)81472-0 ↗
19. 10.1053/jvet.2001.1784910.1053/jvet.2001.17849 ↗
20. 10.1177/03000605990270060510.1177/030006059902700605 ↗
21. 10.1080/08941939927253910.1080/089419399272539 ↗
22. Preclinical evaluation of Seprafilm bioresorbable membrane
23. 10.1067/msy.2001.11510210.1067/msy.2001.115102 ↗
24. 10.1016/S0142-9612(01)00418-510.1016/S0142-9612(01)00418-5 ↗
25. 10.1007/978-94-017-1217-0_1010.1007/978-94-017-1217-0_10 ↗
26. 10.1007/0-306-47583-9_410.1007/0-306-47583-9_4 ↗
27. Pitt CG · 1990 · 71
28. 10.1016/S0142-9612(99)00155-610.1016/S0142-9612(99)00155-6 ↗
29. 10.1016/S0142-9612(97)00080-X10.1016/S0142-9612(97)00080-X ↗
30. 10.1016/S0266-3538(03)00178-710.1016/S0266-3538(03)00178-7 ↗
31. 10.1016/S1359-0294(03)00004-910.1016/S1359-0294(03)00004-9 ↗
32. 10.1002/pol.1981.18019060110.1002/pol.1981.180190601 ↗
33. 10.1016/j.colsurfb.2003.12.00410.1016/j.colsurfb.2003.12.004 ↗
34. 10.1002/jbm.1016710.1002/jbm.10167 ↗
35. 10.1016/S0142-9612(03)00593-310.1016/S0142-9612(03)00593-3 ↗
36. 10.1016/j.biomaterials.2003.08.04210.1016/j.biomaterials.2003.08.042 ↗
37. 10.1163/15685620577457665510.1163/156856205774576655 ↗
38. 10.1016/S0142-9612(00)00098-310.1016/S0142-9612(00)00098-3 ↗
39. Jansen JA · 1999 · 393
40. 10.1001/archsurg.134.11.125410.1001/archsurg.134.11.1254 ↗
41. 10.1002/bjs.180071072210.1002/bjs.1800710722 ↗
42. 10.1016/0002-9610(89)90281-X10.1016/0002-9610(89)90281-X ↗
43. 10.1001/archsurg.1997.0143036004000810.1001/archsurg.1997.01430360040008 ↗
44. 10.1016/0002-9610(72)90332-710.1016/0002-9610(72)90332-7 ↗
45. The effect of one prophylactic dosage of antibiotics on experimentally induced lethal intra‐abdominal sepsis
46. A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis
47. 10.1006/jsre.2001.624510.1006/jsre.2001.6245 ↗
48. Tito WA · 1996 · 375
49. 10.1016/S0015-0282(16)47768-X10.1016/S0015-0282(16)47768-X ↗
50. 10.1002/bjs.180081074010.1002/bjs.1800810740 ↗
51. 10.1016/S0032-3861(02)00275-610.1016/S0032-3861(02)00275-6 ↗
52. 10.1016/S0168-3659(02)00041-X10.1016/S0168-3659(02)00041-X ↗
53. 10.1097/01.sla.0000143302.48223.7e10.1097/01.sla.0000143302.48223.7e ↗
54. 10.3748/wjg.v9.i3.56810.3748/wjg.v9.i3.568 ↗
55. Prevention of intraperitoneal adhesions by intraperitoneal lavage and intraperitoneal 5‐fluorouracil: Experimental studies
56. The formation of coalescing peritoneal adhesions requires injury to both contacting peritoneal surfaces10.1016/S0015-0282(16)56660-6 ↗